Neurocrine Biosciences Inc.

09/30/2024 | Press release | Distributed by Public on 09/30/2024 07:01

Neurocrine Biosciences Presents Interim Data Demonstrating Robust and Sustained Improvements in Chorea Associated With Huntington's Disease Through Week 104 Irrespective of[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.